共 69 条
- [1] Boscoe AN(2019)Impact of refractory myasthenia gravis on health-related quality of life J Clin Neuromuscul Dis 20 173-181
- [2] Xin H(2022)Utilization of MG-ADL in myasthenia gravis clinical research and care Muscle Nerve 65 630-639
- [3] Ltalien GJ(2016)International consensus guidance for management of myasthenia gravis: executive summary Neurology 87 419-425
- [4] Harris LA(2016)Myasthenia gravis—autoantibody characteristics and their implications for therapy Nat Rev Neurol 12 259-268
- [5] Cutter GR(2020)Determinants of quality of life in myasthenia gravis patients Front Neurol 11 512-516
- [6] Muppidi S(2001)Quality of life and well-being of patients with myasthenia gravis Muscle Nerve 24 e066445-1489
- [7] Silvestri NJ(2022)The humanistic burden of myasthenia gravis: a systematic literature review J Neurol Sci 437 1487-459
- [8] Tan R(2023)Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG BMJ Open 13 452-1257
- [9] Riggs K(1999)Myasthenia gravis activities of daily living profile Neurology 52 1245-21
- [10] Leighton T(2019)EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis Eur J Neurol 26 5-300